Business Description
Artiva Biotherapeutics is a San Diego-based clinical-stage company, founded in 2019, that develops treatments using natural killer cells ? a type of immune cell the body uses to fight disease. Its main therapy, AlloNK, is a ready-to-use cell treatment being studied for a range of autoimmune conditions as well as certain blood cancers. The company is also advancing two additional cell-based treatments aimed at solid tumors, including breast, gastric, and bladder cancers, and at other blood-related cancers.
